Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Design

Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current Pandemic scenario, all articles related to Coronavirus will be processed on a quick track basis, to ensure timely review and publication of much needed research

Contents

Current Pharmaceutical Design, Volume 17 - Number 20


Mitochondrial Dysfunction and Targeted Drugs: A Focus on Diabetes

, 17(20): 1986 - 2001

Victor M Victor, Milagros Rocha, Celia Banuls, Lorena Bellod and Antonio Hernandez-Mijares


DOI: 10.2174/138161211796904722




Principles and Therapeutic Relevance for Targeting Mitochondria in Aging and Neurodegenerative Diseases

, 17(20): 2036 - 2055

Gaetano Serviddio, Antonino Davide Romano, Tommaso Cassano, Francesco Bellanti, Emanuele Altomare and Gianluigi Vendemiale


DOI: 10.2174/138161211796904740





Drug-induced Cardiac Mitochondrial Toxicity and Protection: From Doxorubicin to Carvedilol

, 17(20): 2113 - 2129

Goncalo C. Pereira, Ana M. Silva, Catia V. Diogo, Filipa S. Carvalho, Pedro Monteiro and Paulo J. Oliveira


DOI: 10.2174/138161211796904812




Editor-in-Chief

William A. Banks
(45093 citations)
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
(USA)

Biography View Full Editorial Board

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

Journal History

Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks, who is the current Editor-in-Chief serving since 1995.
Scopus CiteScore Metrics: 2.32

Advertisement

Covid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog